Samsung Electronics Co., Ltd.

Young Mi Oh

Kyung Ah Kim

Saet Byoul Lee

Ji Min Lee

Kwang Ho Cheong

Yun Ju Jeong

Jae Young Choi

Seung Hyun Lee

Seunghyun Lee

Geun Tak Kim

Mi Young Cho

Bo Gyou Kim

Yun Jeong Song

Ho Yeong Song

Kyung-ah Kim

Soo-yeon Jung

Geun Woong Kim

Yunju Jeong

Yoon Aa Choi

Hye Won Park

Young Kue Han

A method of preventing and/or treating a cancer comprising co-administering a p53 activator and a c-Met inhibitor to a patient in need thereof.

Combination therapy using P53 activator and c-Met inhibitor

A method for prevention or treatment of a cancer, comprising co-administering (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib or a combination thereof, to a subject in need thereof, and a pharmaceutical composition comprising (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib, or a combination thereof are provided.

Method of combination therapy using an anti-C-Met antibody

A method of identifying a cell sample or a subject suitable for treatment with an anti-c-Met antibody or antigen binding fragment thereof that specifically binds to an epitope within a SEMA domain of a c-Met protein by determining a Cbl concentration, a Cbl mutation, and/or a mutation of a site of c-Met for interaction with Cbl in a cell sample from a subject, as well as related compositions and methods.

Use of Cbl as biomarker for identifying subject suitable for treatment with anti-c-Met antibody

An anti c-Met antibody, a composition comprising the antibody, and a method for preventing or treating cancer by administering the composition is provided.

Anti c-Met humanized antibody and uses thereof

Growing community of inventors

Seoul, South Korea

Young Mi Oh